Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
Clin Transl Gastroenterol
; 11(12): e00271, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-33512798
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Trypsin Inhibitor, Kazal Pancreatic
/
Carcinoma, Hepatocellular
/
Early Detection of Cancer
/
Liver Neoplasms
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Transl Gastroenterol
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos